Morgan Dempsey Capital Management LLC decreased its stake in shares of Stericycle, Inc. (NASDAQ:SRCL) by 2.5% during the second quarter, Holdings Channel reports. The institutional investor owned 1,854 shares of the business services provider’s stock after selling 48 shares during the period. Morgan Dempsey Capital Management LLC’s holdings in Stericycle were worth $141,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of SRCL. BlackRock Inc. boosted its position in Stericycle by 3,492.3% in the first quarter. BlackRock Inc. now owns 5,089,580 shares of the business services provider’s stock valued at $421,877,000 after buying an additional 4,947,900 shares in the last quarter. Ameriprise Financial Inc. boosted its position in Stericycle by 144.9% in the first quarter. Ameriprise Financial Inc. now owns 1,901,243 shares of the business services provider’s stock valued at $157,594,000 after buying an additional 1,124,908 shares in the last quarter. Wedge Capital Management L L P NC bought a new position in Stericycle during the first quarter valued at about $43,949,000. Wells Fargo & Company MN boosted its position in Stericycle by 25.5% in the first quarter. Wells Fargo & Company MN now owns 1,956,193 shares of the business services provider’s stock valued at $162,149,000 after buying an additional 398,076 shares in the last quarter. Finally, Jennison Associates LLC boosted its position in Stericycle by 32.7% in the first quarter. Jennison Associates LLC now owns 1,417,498 shares of the business services provider’s stock valued at $117,496,000 after buying an additional 349,371 shares in the last quarter. Institutional investors and hedge funds own 95.16% of the company’s stock.

Stericycle, Inc. (NASDAQ SRCL) opened at 71.44 on Friday. The company’s market cap is $6.09 billion. Stericycle, Inc. has a 52 week low of $70.24 and a 52 week high of $88.00. The stock has a 50 day moving average of $76.62 and a 200 day moving average of $80.50.

Stericycle (NASDAQ:SRCL) last issued its earnings results on Thursday, August 3rd. The business services provider reported $1.15 EPS for the quarter, beating the Zacks’ consensus estimate of $1.13 by $0.02. The firm had revenue of $917.70 million for the quarter, compared to analyst estimates of $902.81 million. Stericycle had a positive return on equity of 14.35% and a negative net margin of 0.07%. Stericycle’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.18 earnings per share. Equities research analysts predict that Stericycle, Inc. will post $4.60 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece of content was first posted by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/11/stericycle-inc-nasdaqsrcl-shares-sold-by-morgan-dempsey-capital-management-llc.html.

SRCL has been the topic of several research analyst reports. Robert W. Baird cut shares of Stericycle from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $74.00 to $73.00 in a research note on Friday, May 5th. Deutsche Bank AG lowered their target price on shares of Stericycle from $14.00 to $10.00 and set a “buy” rating on the stock in a research note on Monday, May 15th. Barclays PLC initiated coverage on shares of Stericycle in a research note on Thursday, April 13th. They set an “overweight” rating and a $100.00 target price on the stock. Zacks Investment Research cut shares of Stericycle from a “buy” rating to a “hold” rating in a research note on Tuesday, May 2nd. Finally, BMO Capital Markets initiated coverage on shares of Stericycle in a research note on Thursday, June 29th. They set a “market perform” rating and a $81.00 target price on the stock. Four research analysts have rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $81.15.

About Stericycle

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle, Inc. (NASDAQ:SRCL).

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.